Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.7371
-0.0467 (-5.96%)
At close: Aug 26, 2026, 4:00 PM EDT
0.7350
-0.0021 (-0.28%)
Pre-market: Aug 27, 2026, 7:06 AM EDT
Fractyl Health Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
117.33M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 93.00K | -27.00K | -22.50% |
| Dec 31, 2023 | 120.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Seer, Inc. | 14.22M |
| Coya Therapeutics | 8.02M |
| Rani Therapeutics Holdings | 4.88M |
| NeOnc Technologies Holdings | 39.99K |
| Genelux | 8.00K |
GUTS News
- 2 days ago - Fractyl Health Proxy statement: Proxy filing - Filings
- 7 days ago - Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance - GlobeNewsWire
- 12 days ago - Fractyl Health Proxy statement: Proxy filing - Filings
- 14 days ago - Fractyl Health Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 16 days ago - Fractyl Health reports Q2 EPS (16c), consensus (14c) - TheFly
- 16 days ago - Fractyl Health Earnings Call Transcript: Q2 2026 - Transcripts
- 16 days ago - Fractyl Health Earnings release: Q2 2026 - Filings
- 16 days ago - Fractyl Health Quarterly report: Q2 2026 - Filings